Fundz

Parent Project Muscular Dystrophy Invests $1 Million in Satellos Bioscience to Support New Regenerative Medicine Technology

PRIVATEJan 19, 2021
United StatesHealth CareNon Profit

Description

 Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), today announced a $1 million programmatic investment in Satellos Bioscience Inc. (Satellos) to support the development of a new regenerative medicine for the therapeutic treatment of Duchenne.

Quick answer

Parent Project Muscular Dystrophy raised an undisclosed amount in a funding round, dated January 19, 2021. Parent Project Muscular Dystrophy is based in United States.

How much did Parent Project Muscular Dystrophy raise?
Parent Project Muscular Dystrophy raised an undisclosed amount in a funding round on January 19, 2021.
What does Parent Project Muscular Dystrophy do?
Parent Project Muscular Dystrophy (PPMD) is a nonprofit organization dedicated to ending Duchenne, a genetic disorder that gradually weakens muscles.
Where is Parent Project Muscular Dystrophy based and how big is it?
Parent Project Muscular Dystrophy is based in United States.
Who are the decision-makers at Parent Project Muscular Dystrophy?
Fundz holds 1 contact at Parent Project Muscular Dystrophy. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Non Profit and Health Care around the same time

Companies in the same sectors as Parent Project Muscular Dystrophy that raised within 45 days of this round, from Fundz verified event records.

  • Distinct Dermatology raised $1.2M (Seed) on March 5, 2021.
  • Oxehealth raised an undisclosed amount on March 5, 2021.
  • Variantyx raised $16M on March 5, 2021.
  • Sycamore Biopharma raised an undisclosed amount on March 5, 2021.
  • Fresenius Medical Care raised $3.6M on March 4, 2021.
  • BurnAlong, Inc. raised $3.9M (Seed) on March 4, 2021.

Who to call at Parent Project Muscular Dystrophy, and when

A new round usually means Parent Project Muscular Dystrophy is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Parent Project Muscular Dystrophy raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Parent Project Muscular Dystrophy, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Parent Project Muscular Dystrophy. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Parent Project Muscular Dystrophy

Location

United States

About

Parent Project Muscular Dystrophy (PPMD) is a nonprofit organization dedicated to ending Duchenne, a genetic disorder that gradually weakens muscles. Since its founding in 1994, PPMD has fought to ensure families have access to expert care, cutting-edge treatments, and a strong support community. The organization invests deeply in therapies for today’s patients while driving research for future generations, and its advocacy efforts have secured hundreds of millions in funding and led to eight FDA approvals. Everything PPMD does is aimed at helping those with Duchenne live longer, stronger lives—and it will not rest until the disease is ended for all.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Parent Project Muscular Dystrophy raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Parent Project Muscular Dystrophy's next move

See what Strategic adds

Parent Project Muscular Dystrophy raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.